BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1469935)

  • 21. The bioavailability of sustained release nicotinic acid formulations.
    Neuvonen PJ; Roivas L; Laine K; Sundholm O
    Br J Clin Pharmacol; 1991 Oct; 32(4):473-6. PubMed ID: 1958442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic findings in niacin-induced hepatitis.
    Scheer MS; Perlmutter S; Ross W; Katz DS
    J Ultrasound Med; 1999 Apr; 18(4):321-3. PubMed ID: 10206223
    [No Abstract]   [Full Text] [Related]  

  • 23. Niacin-induced hepatotoxicity: unusual presentations.
    Coppola A; Brady PG; Nord HJ
    South Med J; 1994 Jan; 87(1):30-2. PubMed ID: 8284714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic acidosis associated with high-dose niacin therapy.
    Earthman TP; Odom L; Mullins CA
    South Med J; 1991 Apr; 84(4):496-7. PubMed ID: 2014436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin.
    Etchason JA; Miller TD; Squires RW; Allison TG; Gau GT; Marttila JK; Kottke BA
    Mayo Clin Proc; 1991 Jan; 66(1):23-8. PubMed ID: 1988755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety profile of extended-release niacin in the AIM-HIGH trial.
    Anderson TJ; Boden WE; Desvigne-Nickens P; Fleg JL; Kashyap ML; McBride R; Probstfield JL;
    N Engl J Med; 2014 Jul; 371(3):288-90. PubMed ID: 25014706
    [No Abstract]   [Full Text] [Related]  

  • 27. Niacin: a therapeutic dilemma. "One man's drink is another's poison".
    Kreisberg RA
    Am J Med; 1994 Oct; 97(4):313-6. PubMed ID: 7942931
    [No Abstract]   [Full Text] [Related]  

  • 28. Correction of refractory thrombocytopenia and anemia following withdrawal of extended release niacin.
    O'Connell C; Horwood K; Nadamuni M
    Am J Hematol; 2016 Jul; 91(7):E318. PubMed ID: 27012809
    [No Abstract]   [Full Text] [Related]  

  • 29. When taking niacin to help lower my LDL and raise my HDL, I have experienced a hot and itchy "flushing" sensation, which I understand is very common. Are there any "no flush" niacin products on the market?
    Heart Advis; 2007 Nov; 10(11):8. PubMed ID: 18271102
    [No Abstract]   [Full Text] [Related]  

  • 30. Important considerations for treatment with dietary supplement versus prescription niacin products.
    Backes JM; Padley RJ; Moriarty PM
    Postgrad Med; 2011 Mar; 123(2):70-83. PubMed ID: 21474895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case for immediate-release niacin.
    Bassan M
    Heart Lung; 2012; 41(1):95-8. PubMed ID: 21414665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinic acid decreases serum thyroid hormone levels while maintaining a euthyroid state.
    Shakir KM; Kroll S; Aprill BS; Drake AJ; Eisold JF
    Mayo Clin Proc; 1995 Jun; 70(6):556-8. PubMed ID: 7776715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and tolerability of extended-release niacin with laropiprant.
    Yadav R; Kwok S; Ammori BJ; Issa B; Soran H
    Expert Opin Drug Saf; 2012 Jan; 11(1):151-9. PubMed ID: 22133050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Niacin and statin intolerable for some people.
    Tofield A
    Eur Heart J; 2013 Sep; 34(33):2579. PubMed ID: 24137778
    [No Abstract]   [Full Text] [Related]  

  • 35. Nutrition. Pilot study suggests high-dose niacin is safe and effective for some PHAs.
    TreatmentUpdate; 2004 Oct; 16(6):6-7. PubMed ID: 17219680
    [No Abstract]   [Full Text] [Related]  

  • 36. Managing lipid disorders.
    Becker G
    Iowa Med; 1990 Apr; 80(4):207. PubMed ID: 2335469
    [No Abstract]   [Full Text] [Related]  

  • 37. [The toxicology of certain dithiocarbamates].
    Ivanova-Chemishanska L
    Gig Sanit; 1971 Nov; 36(11):95-8. PubMed ID: 5149208
    [No Abstract]   [Full Text] [Related]  

  • 38. Side effects and complications. Extended-release high-dose niacin helps lower lipid levels.
    TreatmentUpdate; 2005 Dec; 17(7):7-8. PubMed ID: 17225322
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and side effects of sustained-release niacin.
    Weiner M
    JAMA; 1994 Aug; 272(7):514; author reply 514-5. PubMed ID: 8093175
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical trial of oat bran and niacin in the treatment of hyperlipidemia.
    Keenan JM; Wenz JB; Ripsin CM; Huang Z; McCaffrey DJ
    J Fam Pract; 1992 Mar; 34(3):313-9. PubMed ID: 1541958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.